Hassan Bawa , Kabiru Mohammed , Abdulrazak Nuhu , Abdulmalik Shuaibu , Farhan Rhidor Akorede , Olalekan Adesola , Muhammad Bashir Bello , Abdurrahman Hassan Jibril
{"title":"Carbapenemase-producing Pseudomonas aeruginosa isolated from patients exhibited multidrug resistance in Sokoto, Nigeria","authors":"Hassan Bawa , Kabiru Mohammed , Abdulrazak Nuhu , Abdulmalik Shuaibu , Farhan Rhidor Akorede , Olalekan Adesola , Muhammad Bashir Bello , Abdurrahman Hassan Jibril","doi":"10.1016/j.medmic.2025.100134","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Carbapenemase-producing <em>P. aeruginosa</em> is one of the top priority pathogens responsible for treatment failures in cystic fibrosis, abscess and soft tissue infections. The study aimed to determine the prevalence of carbapenemase-producing <em>P. aeruginosa</em> in patients visiting two major public hospitals in Sokoto, Nigeria.</div></div><div><h3>Methods</h3><div>Two hundred and four samples were collected from in- and outpatients attending two major public hospitals in Sokoto, Nigeria. Identifying <em>P. aeruginosa</em> involved culturing on cetrimide agar and confirming by PCR detection of the <em>oprI</em> and <em>oprL</em> genes <em>specific to P. aeruginosa.</em> Isolates were screened for sensitivity to ten antibiotics using the Kirby-Bauer disc diffusion test. To identify carbapenemase production, isolates resistant to meropenem and imipenem were further screened using the combined disc synergy test. Molecular detection of carbapenemase was done using PCR detection of <em>bla</em><sub>VIM</sub>, <em>bla</em><sub>KPC</sub> and <em>bla</em><sub>IMP</sub> genes.</div></div><div><h3>Results</h3><div>Out of the 204 samples collected, 26 (12.7 %) of <em>P. aeruginosa</em> were recovered. All 26 isolates demonstrated resistance to more than three classes of antibiotics tested. Notably, 19.2 % (5/26) of the isolates were pan-drug-resistant to all antibiotics tested. Besides, 65.4 % (14/26) of isolates were at least resistant to ampicillin, kanamycin, cefotaxime, trimethoprim and chloramphenicol. A combined disk synergy test showed six isolates to produce carbapenemase enzyme. Likewise, <em>bla</em><sub>VIM</sub> and <em>bla</em><sub>IMP</sub> were detected in all of these isolates, while <em>bla</em><sub>KPC</sub> was not detected in any.</div></div><div><h3>Conclusions</h3><div>The presence of carbapenemase-producing <em>P. aeruginosa</em> (carrying <em>bla</em><sub>VIM</sub> and <em>bla</em><sub>IMP</sub> genes) among hospital patients in Sokoto and the high antibiotic resistance detected represent a challenging threat to public health. Further research is crucial to understanding this carbapenemase gene's transmission source and developing effective strategies to combat it.</div></div>","PeriodicalId":36019,"journal":{"name":"Medicine in Microecology","volume":"25 ","pages":"Article 100134"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine in Microecology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590097825000151","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Carbapenemase-producing P. aeruginosa is one of the top priority pathogens responsible for treatment failures in cystic fibrosis, abscess and soft tissue infections. The study aimed to determine the prevalence of carbapenemase-producing P. aeruginosa in patients visiting two major public hospitals in Sokoto, Nigeria.
Methods
Two hundred and four samples were collected from in- and outpatients attending two major public hospitals in Sokoto, Nigeria. Identifying P. aeruginosa involved culturing on cetrimide agar and confirming by PCR detection of the oprI and oprL genes specific to P. aeruginosa. Isolates were screened for sensitivity to ten antibiotics using the Kirby-Bauer disc diffusion test. To identify carbapenemase production, isolates resistant to meropenem and imipenem were further screened using the combined disc synergy test. Molecular detection of carbapenemase was done using PCR detection of blaVIM, blaKPC and blaIMP genes.
Results
Out of the 204 samples collected, 26 (12.7 %) of P. aeruginosa were recovered. All 26 isolates demonstrated resistance to more than three classes of antibiotics tested. Notably, 19.2 % (5/26) of the isolates were pan-drug-resistant to all antibiotics tested. Besides, 65.4 % (14/26) of isolates were at least resistant to ampicillin, kanamycin, cefotaxime, trimethoprim and chloramphenicol. A combined disk synergy test showed six isolates to produce carbapenemase enzyme. Likewise, blaVIM and blaIMP were detected in all of these isolates, while blaKPC was not detected in any.
Conclusions
The presence of carbapenemase-producing P. aeruginosa (carrying blaVIM and blaIMP genes) among hospital patients in Sokoto and the high antibiotic resistance detected represent a challenging threat to public health. Further research is crucial to understanding this carbapenemase gene's transmission source and developing effective strategies to combat it.